Australië - Engels - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - telaprevir -

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - lisinopril dihydrate 10.89mg equivalent to 10 mg lisinopril;   - tablet - 10 mg - active: lisinopril dihydrate 10.89mg equivalent to 10 mg lisinopril   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate mannitol pregelatinised maize starch starch - lisinopril is indicated in the treatment of essential hypertension and in renovascular hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - lisinopril dihydrate 21.78mg equivalent to 20 mg lisinopril;   - tablet - 20 mg - active: lisinopril dihydrate 21.78mg equivalent to 20 mg lisinopril   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide pregelatinised maize starch magnesium stearate mannitol starch - lisinopril is indicated in the treatment of essential hypertension and in renovascular hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - lisinopril dihydrate 5.445mg equivalent to 5.0 mg lisinopril;   - tablet - 5 mg - active: lisinopril dihydrate 5.445mg equivalent to 5.0 mg lisinopril   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide pregelatinised maize starch magnesium stearate mannitol starch - lisinopril is indicated in the treatment of essential hypertension and in renovascular hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - roxithromycin 150mg;   - coated tablet - 150 mg - active: roxithromycin 150mg   excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water - adults roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible micro-organisms: · upper respiratory tract infection - acute pharyngitis, tonsillitis and sinusitis · dental infections · lower respiratory tract infection - acute bronchitis; acute exacerbations of chronic bronchitis and community acquired pneumonia · skin and skin structure infections · non-gonococcal urethritis. children roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis, acute tonsillitis and impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - roxithromycin 300mg;   - coated tablet - 300 mg - active: roxithromycin 300mg   excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg - film coated tablet - 1 mg - active: tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg - film coated tablet - 2 mg - active: tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 25mg - film coated tablet - 25 mg - active: topiramate 25mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 100mg - film coated tablet - 100 mg - active: topiramate 100mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry yellow 80w62681 pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .